Spontaneous Increases in Alanine Aminotransferase Levels in Asymptomatic Chronic Hepatitis B Virus-Infected Patients

被引:48
作者
Kumar, Manoj [2 ]
Chauhan, Ranjit [1 ]
Gupta, Nitin [1 ]
Hissar, Syed [1 ]
Sakhuja, Puja [3 ]
Sarin, Shiv K. [1 ,2 ]
机构
[1] GB Pant Hosp, Dept Gastroenterol, New Delhi 110002, India
[2] Inst Liver & Billary Sci, Dept Hepatol, New Delhi 110002, India
[3] GB Pant Hosp, Dept Pathol, New Delhi 110002, India
关键词
LIVER-DISEASE PATIENTS; E-ANTIGEN; CORE PROMOTER; PRECORE REGION; CONSENSUS STATEMENT; NATURAL-HISTORY; GENOTYPE-A; MUTATIONS; SEROCONVERSION; CARRIERS;
D O I
10.1053/j.gastro.2009.01.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background & Aims: No information is available about the frequency or factors that predict spontaneous increases in alanine aminotransferase (ALT) levels in asymptomatic Indian patients with chronic hepatitis B virus (HBV) infection who are HB e antigen (HBeAg) negative and have normal ALT levels. Methods: We followed 217 asymptomatic patients with chronic HBV who were HBeAg negative, anti-HBe antigen (anti-HBe) positive, and had normal ALT levels. Spontaneous increases in ALT levels (ALT flares) were considered to be >2-fold the upper limit of normal (ULN) and were accompanied by HBV DNA levels >= 10(5) copies/mL or a 100-fold increase from the previously measured level. Results: During a median follow-up period of 69.0 months, spontaneous ALT flares occurred in 43 patients (an annual rate of 4.3%), with cumulative probabilities of 10.8% and 47.3% after 5 and 10 years, respectively. Based on multinomial logistic regression, the probability of an ALT flare correlated with age >= 30 years at presentation (odds ratio [OR], 5.31; 95% confidence interval [CI]: 1.53-18.39; P = .008), male sex (OR, 4.54; 95% CI: 1.01-20.76; P = .05), and presence of a precore mutation (OR, 10.99; 95% CI: 3.67-32.92; P < .001). The median time to spontaneous ALT flare after enrollment was 25 months (range, 1-128 months; 10th percentile = 3.4 months). Conclusions: In asymptomatic patients with chronic HBV infection who have normal ALT levels and are HBeAg negative, the annual rate of ALT flares was 4.3%. Precore mutants, male sex, and age 2:30 years at presentation are independent predictors for an ALT flare. A follow-up every 3 months can capture up to 90% of flares and would help identify patients who require antiviral therapy.
引用
收藏
页码:1272 / 1280
页数:9
相关论文
共 32 条
[1]
Hepatitis B virus genotypes in chronic liver disease patients from New Delhi, India [J].
Chattopadhyay, Saket ;
Das, Bhudev Chandra ;
Kar, Premashis .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (41) :6702-6706
[2]
Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India [J].
Chauhan, R ;
Kazim, SN ;
Bhattacharjee, J ;
Sakhuja, P ;
Sarin, SK .
JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (08) :1047-1054
[3]
Identification and characterization of genotype A and D recombinant hepatitis B virus from Indian chronic HBV isolates [J].
Chauhan, Ranjit ;
Kazim, Syed Naqui ;
Kumar, Manoj ;
Bhattacharjee, Jayashree ;
Krishnamoorthy, Narayanasamy ;
Sarin, Shiv Kumar .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (40) :6228-6236
[4]
Spontaneous relapse of hepatitis in inactive HBsAg carriers [J].
Chu, Chia-Ming ;
Liaw, Yun-Fan .
HEPATOLOGY INTERNATIONAL, 2007, 1 (02) :311-315
[5]
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B [J].
Chu, Chia-Ming ;
Liaw, Yun-Fan .
GASTROENTEROLOGY, 2007, 133 (05) :1458-1465
[6]
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up [J].
Chu, Chia-Ming ;
Liaw, Yun-Fan .
HEPATOLOGY, 2007, 45 (05) :1187-1192
[7]
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels [J].
Chu, CM ;
Hung, SJ ;
Lin, J ;
Tai, DI ;
Liaw, YF .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (12) :829-834
[8]
Chu CM, 2004, CURR HEPAT REP, V3, P123, DOI DOI 10.1007/S11901-004-0021-X
[9]
EASL International Concensus Conference on Hepatitis B -: 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) [J].
de Franchis, R ;
Hadengue, A ;
Lau, G ;
Lavanchy, D ;
Lok, A ;
McIntyre, N ;
Mele, A ;
Paumgartner, G ;
Pietrangelo, A ;
Rodés, J ;
Rosenberg, W ;
Valla, D .
JOURNAL OF HEPATOLOGY, 2003, 39 :S3-S25
[10]
Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B [J].
Feld, Jordan J. ;
Ayers, Melissa ;
El-Ashry, Dahlia ;
Mazzulli, Tony ;
Tellier, Raymond ;
Heathcote, E. Jenny .
HEPATOLOGY, 2007, 46 (04) :1057-1070